Abstract
A PHYSIOLOGICAL role for the dopamine D1 receptor has been difficult to define, particularly because of its complex pre- and postsynaptic localization in brain areas such as the striatum1. In the midbrain, however, D1 receptors are selectively localized to the terminals of GABA (γ-aminobutyric acid)-containing afferents2–4. We have studied the actions of these D1 receptors on evoked GABA synaptic potentials recorded intracellularly from dopamine neurons in the ventral tegmental area (VTA). We report here that dopamine augmented GABAB inhibitory postsynaptic potentials (i.p.s.ps) in the presence of D2 receptor antagonists. This effect was mimicked by the D1 agonists SKF38393 and SKF82958 and blocked by the D1 antagonists SCH23390 and cis-flupenthixol. No modulation of the GABAA synaptic potential was observed. The postsynaptic actions of the GABABagonist, baclofen, were unaffected by SKF38393, SCH23390 or cis-flupenthixol, confirming a presynaptic locus of D1 action. Additionally, D1 antagonists reduced the amplitude of the GABAB i.p.s.p. in the absence of D1 agonists. We conclude that dopamine acts tonically at presynaptic D1 receptors on the terminals of afferent GABA neurons to facilitate selectively GABAB-mediated neurotransmission in the midbrain.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Surmeier, D. J., Reiner, A., Levine, M. S. & Ariano, M. A. Trends Neurosci. 16, 299–305 (1993).
Harrison, M. B., Wiley, R. G. & Wooten, G. F. Brain Res. 528, 317–322 (1990).
Mansour, A. et al. Neuroscience 42, 359–371 (1991).
Filloux, F. M., Dawson, T. M. & Wamsley, J. K. Brain Res. Bull. 20, 447–459 (1988).
Johnson, S. W. & North, R. A. J. Physiol 450, 455–468 (1992).
Mottola, D. M., Brewster, W. K., Cook, L. L., Nichols, D. E. & Mailman, R. B. J. Pharmac. exp. Ther. 262, 383–393 (1992).
Memo, M., Lovenberg, W. & Hanbauer, I. Proc. natn. Acad. Sci. U.S.A. 79, 4456–4460 (1982).
Balmforth, A. J., Warburton, P. & Ball, S. G. J. Neurochem. 55, 2111–2116 (1990).
Artalejo, C. R., Ariano, M. A., Perlman, R. L. & Fox, A. P. Nature 348, 239–242 (1990).
Geffen, L. B., Jessell, T. M., Cuello, A. C. & Iversen, L. L. Nature 260, 258–260 (1976).
Llinás, R., Greenfield, S. A. & Jahnsen, H. Brain Res. 294, 127–132 (1984).
Davies, C. H., Davies, S. N. & Collingridge, G. L. J. Physiol. 424, 513–531 (1990).
Sugita, S., Johnson, S. W. & North, R. A. Neurosci. Lett. 134, 207–211 (1992).
Johnson, S. W., Mercuri, N. B. & North, R. A. J. Neurosci. 12, 2000–2006 (1992).
Chesselet, M. -F. Neuroscience 12, 347–375 (1984).
Ziogas, J. & Cunnance, T. C. Br. J. Pharmac. 103, 1196–1202 (1991).
Goldsmith, B. A. & Abrams, T. W. Proc. natn. Acad. Sci. U.S.A. 88, 9021–9025 (1991).
Eliot, L. S., Kandel, E. R., Siegelbaum, S. A. & Blumenfeld, H. Nature 361, 634–637 (1993).
Mintz, I. & Korn, H. J. Neurosci. 11, 3359–3370 (1991).
Carlson, J. H., Bergstrom, D. A., Weick, B. G. & Walters, J. R. Synapse 1, 411–416 (1987).
Floran, B., Aceves, J., Sierra, A. & Martinez-Fong, D. Neurosci. Lett. 116, 136–140 (1990).
Reubi, J.-C., Iversen, L. L. & Jessell, T. M. Nature 268, 652–654 (1977).
Civelli, O., Bunzow, J. R. & Grandy, D. K. A. Rev. Pharmac. Toxicol. 33, 281–307 (1993).
Weick, B. G. & Walters, J. R. Brain Res. 405, 234–246 (1987).
Braun, A. R. & Chase, T. N. Eur. J. Pharmac. 131, 301–306 (1986).
Robertson, G. S. & Robertson, H. A. Trends pharmacol. Sci. 8, 295–299 (1987).
Lacey, M. G., Mercuri, N. B. & North, R. A. J. Physiol. 392, 397–416 (1987).
Lacey, M. G., Mercuri, N. B. & North, R. A. J. Physiol. 401, 437–453 (1988).
Williams, J. T., North, R. A., Shefner, S. A., Nishi, S. & Egan, T. M. Neuroscience 13, 137–156 (1984).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cameron, D., Williams, J. Dopamine D1 receptors facilitate transmitter release. Nature 366, 344–347 (1993). https://doi.org/10.1038/366344a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/366344a0
This article is cited by
-
Circuit specificity in the inhibitory architecture of the VTA regulates cocaine-induced behavior
Nature Neuroscience (2017)
-
Dopamine receptor antagonism disrupts social preference in zebrafish: a strain comparison study
Amino Acids (2012)
-
PKG and PKA Signaling in LTP at GABAergic Synapses
Neuropsychopharmacology (2009)
-
Ethanol Enhances Glutamate Transmission by Retrograde Dopamine Signaling in a Postsynaptic Neuron/Synaptic Bouton Preparation From the Ventral Tegmental Area
Neuropsychopharmacology (2009)
-
Anatomically dissociable effects of dopamine D1 receptor agonists on reward and relief of withdrawal in morphine-dependent rats
Psychopharmacology (2009)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.